MAPT and amyloidosis: Within this framework, total tau protein (τΤ), phosphorylated tau protein at threonine 181 (τP-181), and amyloid beta with 42 amino acids (Aβ42) have been classified as markers of neurodegeneration, tau-pathology, and amyloidosis, respectively.